Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02661659
Recruitment Status : Withdrawn (PI stopped study due to inability to accrue.)
First Posted : January 22, 2016
Last Update Posted : May 14, 2018
Sponsor:
Information provided by (Responsible Party):
University of Chicago

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : October 3, 2017
Actual Study Completion Date : October 3, 2017